Preschool impulse oscillometry predicts active asthma and impaired lung function at school age - 04/07/24
, Benjamin J. Stubbs, BA a, Vincent J. Carey, PhD a, Nancy Laranjo, BA a, Robert S. Zeiger, MD, PhD c, Leonard B. Bacharier, MD d, George T. O’Connor, MD, MS e, Scott T. Weiss, MD, MS a, Augusto A. Litonjua, MD, MPH fAbstract |
Background |
Asthmatic symptoms often start during early childhood. Impulse oscillometry (IOS) is feasible in preschool children who may be unable to reliably perform spirometry measurements.
Objective |
We sought to evaluate the use of IOS in a multicenter, multiethnic high-risk asthma cohort titled the Vitamin D Antenatal Asthma Reduction Trial.
Methods |
The trial recruited pregnant women whose children were followed from birth to age 8 years. Lung function was assessed with IOS at ages 4, 5, and 6 years and spirometry at ages 5, 6, 7, and 8 years. Asthma status, respiratory symptoms, and medication use were assessed with repeated questionnaires from birth to age 8 years.
Results |
In total, 220 children were included in this secondary analysis. Recent respiratory symptoms and short-acting β2-agonist use were associated with increased respiratory resistance at 5 Hz at age 4 years (β = 2.6; 95% CI, 1.0 to 4.4; P = .002 and β = 3.4; 95% CI, 0.7 to 6.2; P = .015, respectively). Increased respiratory resistance at 5 Hz at age 4 years was also associated with decreased lung function from ages 5 to 8 years (β = −0.3; 95% CI, −0.5 to −0.1; P < .001 for FEV1 at 8 years) and active asthma at age 8 years (β = 2.0; 95% CI, 0.2 to 3.8; P = .029).
Conclusions |
Increased respiratory resistance in preschool IOS is associated with frequent respiratory symptoms as well as school-age asthma and lung function impairment. Our findings suggest that IOS may serve as a potential objective measure for early identification of children who are at high risk of respiratory morbidity.
Le texte complet de cet article est disponible en PDF.Key words : Impulse oscillometry, spirometry, childhood asthma
Abbreviations used : API, IOS, mAPI, R5, R5-20, SABA, VDAART
Plan
Vol 154 - N° 1
P. 94 - juillet 2024 Retour au numéro
Article précédent
- Dupilumab for chronic spontaneous urticaria—marvelous or meek?
- Sameer K. Mathur, Daniel L. Rosenberg, Ravi K. Viswanathan
- Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma
- Leonard B. Bacharier, Ian D. Pavord, Jorge F. Maspero, Daniel J. Jackson, Alessandro G. Fiocchi, Xuezhou Mao, Juby A. Jacob-Nara, Yamo Deniz, Elizabeth Laws, Leda P. Mannent, Nikhil Amin, Bolanle Akinlade, Heribert W. Staudinger, David J. Lederer, Megan Hardin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?